
    
      After receiving liver transplant, subjects will be randomized to one of the two treatment
      arms.

      Study drugs will be administered for a period of 21 days, or until hospital discharge,
      whichever occurs first.

      Additionally, mortality data will be collected at the Long-term Follow-up.
    
  